Bravecto Plus

RSS

 fluralaner / moxidectin 

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of Bravecto Plus and why it is authorised in the EU

Bravecto Plus is a veterinary medicine used in cats to treat mixed infestations with both ticks and other parasites that may be found on the skin or fur of cats, such as fleas, and/or worms that live inside the body. The medicine can be used:

  • to treat tick infestations
  • to treat flea infestations. It can also be used as part of a treatment for flea allergy dermatitis (an allergic reaction to flea bites)
  • to treat roundworm and hookworm in the gut
  • to prevent heartworm disease

Bravecto Plus must only be used when there is a need to treat ticks or fleas and one or more of the parasites listed above. Bravecto Plus contains the active substances fluralaner and moxidectin.

This EPAR was last updated on 06/06/2018

Authorisation details

Product details
Name
Bravecto Plus
Agency product number
EMEA/V/C/004440
Active substance
  • fluralaner
  • moxidectin
International non-proprietary name (INN) or common name
 fluralaner / moxidectin 
Species
Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP54AB52
Publication details
Marketing-authorisation holder
Intervet International B.V.
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
08/05/2018
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

08/05/2018 Bravecto Plus - EMEA/V/C/004440 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiparasitic products
  • insecticides and repellents
  • ENDECTOCIDES
  • Milbemycins

Therapeutic indication

For cats with, or at risk from, mixed parasitic infestations by ectoparasites (ticks and fleas) together with gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when use against ticks or fleas and one or more of the other target parasites is indicated at the same time.

Assessment history

How useful was this page?

Add your rating